{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:10:27Z","timestamp":1792005027085,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","award":["LF-OC-24-001837"],"award-info":[{"award-number":["LF-OC-24-001837"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC IG 30631"],"award-info":[{"award-number":["AIRC IG 30631"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.tips.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:14:33Z","timestamp":1779412473000},"page":"655-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in CDC42 subfamily inhibition and therapeutic potential"],"prefix":"10.1016","volume":"47","author":[{"given":"Maria Antonietta","family":"La Serra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4022-5661","authenticated-orcid":false,"given":"Marco","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.04.004_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.cellbio.21.020604.150721","article-title":"Rho GTPases: biochemistry and biology","volume":"21","author":"Jaffe","year":"2005","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","article-title":"Rho GTPases: regulation and roles in cancer cell biology","volume":"7","author":"Haga","year":"2016","journal-title":"Small GTPases"},{"key":"10.1016\/j.tips.2026.04.004_bb0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10456-020-09726-w","article-title":"RHOQ is induced by DLL4 and regulates angiogenesis by determining the intracellular route of the Notch intracellular domain","volume":"23","author":"Bridges","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.tips.2026.04.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110641","article-title":"Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer","volume":"39","author":"Jahid","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0025","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1038\/s41417-024-00792-6","article-title":"RhoJ: an emerging biomarker and target in cancer research and treatment","volume":"31","author":"Shen","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0030","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1042\/BST20200557","article-title":"Molecular subversion of Cdc42 signalling in cancer","volume":"49","author":"Murphy","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tips.2026.04.004_bb0035","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7150\/jca.65415","article-title":"The role of cell division control protein 42 in tumor and non-tumor diseases: a systematic review","volume":"13","author":"Fu","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.tips.2026.04.004_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/molecules23040787","article-title":"Regulating Cdc42 and its signaling pathways in cancer: small molecules and microRNA as new treatment candidates","volume":"23","author":"Xiao","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2026.04.004_bb0045","series-title":"Ras Superfamily Small G Proteins: Biology and Mechanisms 1: General Features, Signaling","year":"2014"},{"key":"10.1016\/j.tips.2026.04.004_bb0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tips.2024.11.006","article-title":"ACK1\/TNK2 kinase: molecular mechanisms and emerging cancer therapeutics","volume":"46","author":"Sridaran","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.04.004_bb0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/cm.21768","article-title":"BORG family proteins in physiology and human disease","volume":"80","author":"Tomasso","year":"2023","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.tips.2026.04.004_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf5143","article-title":"Small GTPase Cdc42, WASP, and scaffold proteins for higher-order assembly of the F-BAR domain protein","volume":"9","author":"Wan Mohamad Noor","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.04.004_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.stem.2022.12.008","article-title":"A DLG1-ARHGAP31-CDC42 axis is essential for the intestinal stem cell response to fluctuating niche Wnt signaling","volume":"30","author":"Castillo-Azofeifa","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2026.04.004_bb0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/21541248.2019.1658509","article-title":"Identification of guanine nucleotide exchange factors that increase Cdc42 activity in primary human endothelial cells","volume":"12","author":"Reinhard","year":"2021","journal-title":"Small GTPases"},{"key":"10.1016\/j.tips.2026.04.004_bb0075","article-title":"Turning platelets off and on: role of RhoGAPs and RhoGEFs in platelet activity","volume":"8","author":"Comer","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tips.2026.04.004_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41389-020-0190-7","article-title":"FARP1 boosts CDC42 activity from integrin \u03b1v\u03b25 signaling and correlates with poor prognosis of advanced gastric cancer","volume":"9","author":"Hirano","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.tips.2026.04.004_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112971","article-title":"CDC42-effector interaction inhibitors alter patterns of vessel arborization in skin and tumors in vivo","volume":"28","author":"Vuong","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.tips.2026.04.004_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92654-6","article-title":"Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis","volume":"11","author":"Duan","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0095","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.trecan.2024.11.009","article-title":"KRAS inhibitors: resistance drivers and combinatorial strategies","volume":"11","author":"Isermann","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.tips.2026.04.004_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb.2781","article-title":"Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors","volume":"21","author":"Kast","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0105","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.1038\/s41467-024-54294-y","article-title":"Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation and ER stress","volume":"15","author":"Iannuzzo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.04.004_bb0110","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/35073608","article-title":"Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10","volume":"410","author":"Chiang","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.04.004_bb0115","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1074\/jbc.M410026200","article-title":"Regulation of cystic fibrosis transmembrane regulator trafficking and protein expression by a Rho family small GTPase TC10","volume":"280","author":"Cheng","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0960-9822(07)00486-1","article-title":"Distinct cellular effects and interactions of the Rho-family GTPase TC10","volume":"8","author":"Neudauer","year":"1998","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0125","doi-asserted-by":"crossref","first-page":"36457","DOI":"10.1074\/jbc.M003487200","article-title":"Characterization of TCL, a new GTPase of the Rho family related to TC10 and Cdc42","volume":"275","author":"Vignal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0130","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/dvdy.21309","article-title":"Cdc42 is crucial for the establishment of epithelial polarity during early mammalian development","volume":"236","author":"Wu","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.tips.2026.04.004_bb0135","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1053\/j.gastro.2013.06.021","article-title":"Cdc42 coordinates proliferation, polarity, migration, and differentiation of small intestinal epithelial cells in mice","volume":"145","author":"Melendez","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2026.04.004_bb0140","doi-asserted-by":"crossref","first-page":"16520","DOI":"10.1073\/pnas.0603533103","article-title":"Cdc42GAP deficiency causes Sonic hedgehog-independent holoprosencephaly","volume":"103","author":"Chen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.04.004_bb0145","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1101\/gad.361406","article-title":"Cdc42 controls progenitor cell differentiation and \u03b2-catenin turnover in skin","volume":"20","author":"Wu","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.tips.2026.04.004_bb0150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00018-025-05743-4","article-title":"Cell division cycle protein 42-driven activation of the MKK3\/6-p38 signaling pathway participates in cardiac remodeling in mice","volume":"82","author":"Wen","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tips.2026.04.004_bb0155","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.4049\/jimmunol.1602167","article-title":"The small Rho GTPase TC10 modulates B cell immune responses","volume":"199","author":"Burbage","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.tips.2026.04.004_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/21541248.2020.1809927","article-title":"A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis","volume":"12","author":"Sundararaman","year":"2021","journal-title":"Small GTPases"},{"key":"10.1016\/j.tips.2026.04.004_bb0165","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3390\/cells8060545","article-title":"Building blood vessels\u2014one Rho GTPase at a time","volume":"8","author":"Barlow","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.tips.2026.04.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202004092","article-title":"The distinct localization of CDC42 isoforms is responsible for their specific functions during migration","volume":"223","author":"Ravichandran","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1042\/BST20110702","article-title":"The role of RhoJ in endothelial cell biology and angiogenesis","volume":"39","author":"Leszczynska","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tips.2026.04.004_bb0180","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05838-7","article-title":"RHOJ controls EMT-associated resistance to chemotherapy","volume":"616","author":"Debaugnies","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tips.2026.04.004_bb0185","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/cac2.12459","article-title":"Glutamine metabolic microenvironment drives M2 macrophage polarization to mediate trastuzumab resistance in HER2-positive gastric cancer","volume":"43","author":"Hu","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.tips.2026.04.004_bb0190","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1158\/0008-5472.CAN-17-3719","article-title":"Fibrin stiffness mediates dormancy of tumor-repopulating cells via a Cdc42-driven Tet2 epigenetic program","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2026.04.004_bb0195","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.omto.2022.02.023","article-title":"CIP4 targeted to recruit GTP-Cdc42 involving in invadopodia formation via NF-\u03baB signaling pathway promotes invasion and metastasis of CRC","volume":"24","author":"Hu","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.tips.2026.04.004_bb0200","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41388-023-02594-w","article-title":"The pseudokinase NRBP1 activates Rac1\/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer","volume":"42","author":"Yang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2026.04.004_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41416-022-02032-w","article-title":"PAK and PI3K pathway activation confers resistance to KRASG12C inhibitor sotorasib","volume":"128","author":"Chan","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2026.04.004_bb0210","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/onc.2009.119","article-title":"PAK signaling in oncogenesis","volume":"28","author":"Molli","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2026.04.004_bb0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1479-5876-11-295","article-title":"Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity","volume":"11","author":"Zins","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tips.2026.04.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004806","article-title":"Targeting of Cdc42 GTPase in regulatory T cells unleashes antitumor T-cell immunity","volume":"10","author":"Kalim","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.tips.2026.04.004_bb0225","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1084\/jem.20132209","article-title":"RNA editing in RHOQ promotes invasion potential in colorectal cancer","volume":"211","author":"Han","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2026.04.004_bb0230","doi-asserted-by":"crossref","first-page":"30112","DOI":"10.18632\/oncotarget.15618","article-title":"Expression of Rho GTPases family in melanoma cells and its influence on cytoskeleton and migration","volume":"8","author":"Wen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.tips.2026.04.004_bb0235","article-title":"Knockdown of RhoQ, a member of Rho GTPase, accelerates TGF-\u03b2-induced EMT in human lung adenocarcinoma","volume":"32","author":"Satoh","year":"2022","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0240","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7150\/ijbs.65653","article-title":"RhoJ facilitates angiogenesis in glioblastoma via JNK\/VEGFR2 mediated activation of PAK and ERK signaling pathways","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tips.2026.04.004_bb0245","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10522-022-10008-9","article-title":"Role of a small GTPase Cdc42 in aging and age-related diseases","volume":"24","author":"Umbayev","year":"2023","journal-title":"Biogerontology"},{"key":"10.1016\/j.tips.2026.04.004_bb0250","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.stem.2012.04.007","article-title":"Cdc42 activity regulates hematopoietic stem cell aging and rejuvenation","volume":"10","author":"Florian","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2026.04.004_bb0255","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1093\/brain\/awad184","article-title":"Cdc42 deficiency contributes to the Alzheimer\u2019s disease phenotype","volume":"146","author":"Zhu","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.tips.2026.04.004_bb0260","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13588","article-title":"Regulation of Cdc42 signaling by the dopamine D2 receptor in a mouse model of Parkinson\u2019s disease","volume":"21","author":"Ying","year":"2022","journal-title":"Aging Cell"},{"key":"10.1016\/j.tips.2026.04.004_bb0265","article-title":"Crosstalk between the Rho and Rab family of small GTPases in neurodegenerative disorders","volume":"17","author":"Akhtar","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.tips.2026.04.004_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.905703","article-title":"Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs \u03b2-cell insulin secretion","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tips.2026.04.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505291122","article-title":"Cdc42 defect reveals insights into microvilli organization and function in T cell immunity","volume":"122","author":"Soh","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.04.004_bb0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bbrc.2023.05.099","article-title":"RHOJ as a novel mechanosensitive modulator of endothelial inflammation","volume":"670","author":"Liu","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tips.2026.04.004_bb0285","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nchembio751","article-title":"Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro","volume":"2","author":"Pelish","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0290","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.bcp.2006.03.011","article-title":"The Cdc42 inhibitor secramine B prevents cAMP-induced K+ conductance in intestinal epithelial cells","volume":"71","author":"Pelish","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2026.04.004_bb0295","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2006.02.009","article-title":"Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components","volume":"13","author":"Peterson","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0300","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41375-018-0251-5","article-title":"Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization","volume":"33","author":"Liu","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.tips.2026.04.004_bb0305","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3389\/fonc.2019.00958","article-title":"Rational targeting of Cdc42 overcomes drug resistance of multiple myeloma","volume":"9","author":"Nguyen","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tips.2026.04.004_bb0310","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1158\/0008-5472.CAN-14-0267","article-title":"CDC42 inhibition suppresses progression of incipient intestinal tumors","volume":"74","author":"Sakamori","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2026.04.004_bb0315","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/ol8022962","article-title":"Synthesis and biological evaluation of a 5-6-5 imidazole-phenyl-thiazole based \u03b1-helix mimetic","volume":"11","author":"Cummings","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.tips.2026.04.004_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074924","article-title":"A Rac1\/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice","volume":"8","author":"Zins","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2026.04.004_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107165","article-title":"Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42","volume":"203","author":"K\u00fcc\u00fck","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2026.04.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110139","article-title":"Targeting dermatophyte Cdc42 and Rac GTPase signaling to hinder hyphal elongation and virulence","volume":"27","author":"Ishii","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.tips.2026.04.004_bb0335","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/15384047.2018.1564559","article-title":"Inhibition of Cdc42\u2013intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth","volume":"20","author":"Aguilar","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0340","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.1074\/jbc.M111.334524","article-title":"Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase","volume":"287","author":"Montalvo-Ortiz","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0345","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tranon.2014.07.004","article-title":"The Rac inhibitor EHop-016 inhibits mammary tumor growth and metastasis in a nude mouse model","volume":"7","author":"Castillo-Pichardo","year":"2014","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tips.2026.04.004_bb0350","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/cancers17030361","article-title":"RAC1-amplified and RAC1-A159V hotspot-mutated head and neck cancer sensitive to the Rac inhibitor EHop-016in vivo: a proof-of-concept study","volume":"17","author":"Chan","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tips.2026.04.004_bb0355","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01498-21","article-title":"In vitro antimalarial activity of inhibitors of the human GTPase Rac1","volume":"66","author":"Parapini","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.tips.2026.04.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101876","article-title":"The Rac1-inhibitor EHop-016 attenuates AML cell migration and enhances the efficacy of daunorubicin in MOLM-13 transplanted zebrafish larvae","volume":"40","author":"Hemsing","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tips.2026.04.004_bb0365","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1535-7163.MCT-16-0442","article-title":"Characterization of a dual Rac\/Cdc42 inhibitor MBQ-167 in metastatic cancer","volume":"16","author":"Humphries-Bickley","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0370","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1158\/1535-7163.MCT-23-0803","article-title":"Novel inhibition of central carbon metabolism pathways by Rac and Cdc42 inhibitor MBQ-167 and paclitaxel","volume":"23","author":"Cruz-Collazo","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0375","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/1535-7163.MCT-21-0348","article-title":"Efficacy of Rac and Cdc42 inhibitor MBQ-167 in triple-negative breast cancer","volume":"20","author":"Cruz-Collazo","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0380","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1158\/2767-9764.CRC-22-0303","article-title":"Characterization of novel derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac\/Cdc42","volume":"2","author":"Medina","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.tips.2026.04.004_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101928","article-title":"Efficacy and delivery strategies of the dual Rac\/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer","volume":"44","author":"Vel\u00e1zquez-Vega","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.tips.2026.04.004_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1152458","article-title":"Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models","volume":"13","author":"Torres-Sanchez","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tips.2026.04.004_bb0395","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.1116051110","article-title":"Small molecule targeting Cdc42\u2013intersectin interaction disrupts Golgi organization and suppresses cell motility","volume":"110","author":"Friesland","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.04.004_bb0400","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s13046-022-02441-y","article-title":"ARHGEF37 overexpression promotes extravasation and metastasis of hepatocellular carcinoma via directly activating Cdc42","volume":"41","author":"Zhang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tips.2026.04.004_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216702","article-title":"Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer","volume":"587","author":"Liang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tips.2026.04.004_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117329","article-title":"Pharmacokinetic profiling of ZCL-278, a cdc42 inhibitor, and its effectiveness against chronic kidney disease","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2026.04.004_bb0415","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1074\/jbc.M112.435941","article-title":"Characterization of a Cdc42 protein inhibitor and its use as a molecular probe","volume":"288","author":"Hong","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121928","article-title":"Silencing of CDC42 inhibits contraction and growth-related functions in prostate stromal cells, which is mimicked by ML141","volume":"329","author":"Wang","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.tips.2026.04.004_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1449423","article-title":"Cdc42 improve SARS-CoV-2 spike protein-induced cellular senescence through activating of Wnt\/\u03b2-catenin signaling pathway","volume":"14","author":"Nong","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.tips.2026.04.004_bb0430","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13287-018-0910-5","article-title":"Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a\/PI3K\/miR-122 pathway: impact of the age of the donor","volume":"9","author":"Chaker","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0435","first-page":"e407","article-title":"CDC42 inhibitor and the radiosensitivity of non-small cell lung cancer by restraining BRCA1-mediated DNA damage repair","volume":"120","author":"Wang","year":"2024","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.tips.2026.04.004_bb0440","article-title":"Mutation in CDC42 gene set as a response biomarker for immune checkpoint inhibitor therapy","volume":"14","author":"Wang","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.tips.2026.04.004_bb0445","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1087057109352240","article-title":"Identification of a small GTPase inhibitor using a high-throughput flow cytometry bead-based multiplex assay","volume":"15","author":"Surviladze","year":"2010","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.tips.2026.04.004_bb0450","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00638-25","article-title":"Rabies virus utilizes neuropilin 2 as an endocytic receptor to trigger TGFBR1-mediated actin polymerization","volume":"99","author":"Sun","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.tips.2026.04.004_bb0455","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg1778","article-title":"Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1\/2-mediated macropinocytosis","volume":"9","author":"Lu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.04.004_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142182","article-title":"Novel activities of select NSAID R-enantiomers against Rac1 and Cdc42 GTPases","volume":"10","author":"Oprea","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2026.04.004_bb0465","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/jcsm.13422","article-title":"R-ketorolac ameliorates cancer-associated cachexia and prolongs survival of tumour-bearing mice","volume":"15","author":"Chrysostomou","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.tips.2026.04.004_bb0470","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1042\/BJ20120572","article-title":"A novel small-molecule screening strategy identifies mitoxantrone as a RhoGTPase inhibitor","volume":"450","author":"Bidaud-Meynard","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.tips.2026.04.004_bb0475","article-title":"Covalent inhibitors allosterically block the activation of Rho family proteins and suppress cancer cell invasion","volume":"7","author":"Sun","year":"2020","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.04.004_bb0480","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21342-w","article-title":"Discovery of small molecule inhibitors that effectively disrupt IQGAP1-Cdc42 interaction in breast cancer cells","volume":"12","author":"Sayedyahossein","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0485","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1021\/acs.jmedchem.3c00276","article-title":"Design, synthesis, in vitro and in vivo characterization of CDC42 GTPase interaction inhibitors for the treatment of cancer","volume":"66","author":"Brindani","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0490","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1021\/acs.jmedchem.4c00855","article-title":"Discovery of CDC42 inhibitors with a favorable pharmacokinetic profile and anticancer in vivo efficacy","volume":"67","author":"Brindani","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0495","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1074\/jbc.RA119.010077","article-title":"The discovery and maturation of peptide biologics targeting the small G-protein Cdc42: a bioblockade for Ras-driven signaling","volume":"295","author":"Tetley","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0500","doi-asserted-by":"crossref","first-page":"9741","DOI":"10.7150\/thno.46913","article-title":"P21-activated kinase 1: emerging biological functions and potential therapeutic targets in cancer","volume":"10","author":"Yao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.tips.2026.04.004_bb0505","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41416-023-02523-4","article-title":"PAK inhibitor FRAX486 decreases the metastatic potential of triple-negative breast cancer cells by blocking autophagy","volume":"130","author":"Lyu","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.tips.2026.04.004_bb0510","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41392-023-01631-0","article-title":"P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0515","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1038\/onc.2017.143","article-title":"Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis","volume":"36","author":"Semenova","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2026.04.004_bb0520","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41420-025-02677-5","article-title":"Multi-omics analysis reveals RNA polymerase II degradation as a novel mechanism of PF-3758309\u2019s anti-tumor activity","volume":"11","author":"Jia","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.tips.2026.04.004_bb0525","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.stem.2021.06.004","article-title":"Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis","volume":"28","author":"Subedi","year":"2021","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2026.04.004_bb0530","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41417-024-00748-w","article-title":"Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer","volume":"31","author":"Kudo","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0535","article-title":"Large oncosome-loaded VAPA promotes bone-tropic metastasis of hepatocellular carcinoma via formation of osteoclastic pre-metastatic niche","volume":"9","author":"Zhang","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.04.004_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115001","article-title":"Wiskostatin and other carbazole scaffolds as off target inhibitors of dynamin I GTPase activity and endocytosis","volume":"247","author":"Cossar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17685-z","article-title":"Alterations to the broad-spectrum formin inhibitor SMIFH2 modulate potency but not specificity","volume":"12","author":"Orman","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0550","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41417-025-00904-w","article-title":"The activated tyrosine kinase ACK1 by multiple receptor tyrosine kinases promotes proliferation and invasion of mesothelioma via regulation of PI3K\/AKT\/mTOR and RAF\/MAPK signaling pathways","volume":"32","author":"Qiao","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.tips.2026.04.004_bb0555","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s42004-024-01352-7","article-title":"Enabling systemic identification and functionality profiling for Cdc42 homeostatic modulators","volume":"7","author":"Malasala","year":"2024","journal-title":"Commun. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb0560","doi-asserted-by":"crossref","DOI":"10.1038\/srep17527","article-title":"Distinct predictive performance of Rac1 and Cdc42 in cell migration","volume":"5","author":"Yamao","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111321","article-title":"Inflammatory gene regulation by Cdc42 in airway epithelial cells","volume":"122","author":"Shouib","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tips.2026.04.004_bb0570","article-title":"Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy","volume":"32","author":"Elebiyo","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.tips.2026.04.004_bb0575","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fcell.2020.00201","article-title":"Targeting Rac and Cdc42 GEFs in metastatic cancer","volume":"8","author":"Maldonado","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2026.04.004_bb0580","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1042\/BST20210112","article-title":"Progress in the therapeutic inhibition of Cdc42 signalling","volume":"49","author":"Murphy","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.tips.2026.04.004_bb0585","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/embor.2012.75","article-title":"Group I and II mammalian PAKs have different modes of activation by Cdc42","volume":"13","author":"Baskaran","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tips.2026.04.004_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.04.004_bb2005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acs.biochem.5c00616","article-title":"Cyclized peptide inhibitors of the small G protein Cdc42 mimic binding of effector proteins","volume":"65","author":"Murphy","year":"2026","journal-title":"Biochemistry"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561472600088X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016561472600088X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:34:31Z","timestamp":1783092871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016561472600088X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":119,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S016561472600088X"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.04.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in CDC42 subfamily inhibition and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}